| Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. | enzyme inhib; DF: PROTEIN SYN INHIB | Other names Protein Synthesis Antagonists; Inhibitors, Protein Synthesis; Antagonists, Protein Synthesis; Protein Synthesis Antagonists | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Substances having this pharmacologic action: ribosome-inactivating protein type 2, Sambucus; Fusidic Acid; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Neomycin; Anisomycin; Dactinomycin; dianthin proteins, Dianthus caryophyllus; Erythromycin Estolate; Plicamycin; tempol; Pactamycin; S-2-aminoethyl cysteine; 2',5'-oligoadenylate; trichostatin A; Clarithromycin; pokeweed antiviral protein; Cibacron Blue F 3GA; Oxazolidinones; Puromycin; Erythromycin Ethylsuccinate; Sparsomycin; Streptomycin; sordarin; Brefeldin A; alpha-sarcin; linezolid; GEL protein, Gelonium multiflorum; RIP protein, Saponaria officinalis; Chloramphenicol; ranpirnase; Cycloheximide; halofuginone; Emetine; Erythromycin; Methylazoxymethanol Acetate; Amino Acid Chloromethyl Ketones; Olivomycins; Tetracycline; MITF protein, Aspergillus restrictus
| |
|
| | ||||||||||||||||||||||||||||||||||||||||||||||||||||